RE: Independent analysis25 Sep 2022 11:23
Kate, lets break this down..
- 12p or above target for 90 days.
Fincapp also had a broker note for 55p one the way down, to which they forced the price lower, and also, if fincapp who issued the 12p broker note on behalf of ODX were in support of the 12p target, why would they consistently be lowering the SP on a daily basis by being on the top of the bid? They have every opportunity to hold it at lets say 3p on the nose, but they don't and currently at the top of the bid at 2.6p. Their own broker doesn't support the company, or has no confidence in the company getting to 12p as they are doing absolutely nothing, not a thing to help the SP.
- £2.5m cash in bank, no need for overdraft.
ODX is still running at a loss, with the new two years to be a £0.5m loss and the year after £0.3m loss (their own figures taken from their own presentation.
- £4m payment for CD4 when Kenya studies results are released.
You keep banging on about this, and its quite deceitful on your behalf as its not confirmed. Its subject to many technical analysis tests by the WHO and if it doesn't pass them all, there will be no sales, and no £4m. Omega stated its subject to conditions again in the presentation.
- Government dispute talking about 7 figure damages which is £1,000,000 - £9,999,999.
Omega said once again in the presentation, they are "considering".. its not even in motion so at the minute a total non starter.